Correction: Tadalafil Augments Tumor-specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma
Clinical Cancer Research(2018)
Abstract
In the original version of [this article][1] ([1][2]), the authors did not disclose that the investigational agent used, tadalafil, was supplied by Lilly, Inc. This information is now included in the Acknowledgements. The error has been corrected in the latest online HTML and PDF versions of the
MoreTranslated text
Key words
neck squamous cell carcinoma,tumor-specific
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined